References
Anderson, M. G., Frenkel, L. D., Homann, S., & Guffey, J. (2003). A
case of severe monkeypox virus disease in an American child: emerging
infections and changing professional values. Pediatr Infect Dis J,
22 (12), 1093-1096; discussion 1096-1098.
doi:10.1097/01.inf.0000101821.61387.a5
Angelo, K. M., Petersen, B. W., Hamer, D. H., Schwartz, E., & Brunette,
G. (2019). Monkeypox transmission among international
travellers—serious monkey business? In (Vol. 26, pp. taz002): Oxford
University Press.
Babkin, I. V., Babkina, I. N., & Tikunova, N. V. (2022). An Update of
Orthopoxvirus Molecular Evolution. Viruses, 14 (2), 388.
doi:10.3390/v14020388
Baker, R. O., Bray, M., & Huggins, J. W. (2003). Potential antiviral
therapeutics for smallpox, monkeypox and other orthopoxvirus infections.Antiviral Res, 57 (1-2), 13-23. doi:10.1016/s0166-3542(02)00196-1
Bayer-Garner, I. B. (2005). Monkeypox virus: histologic,
immunohistochemical and electron-microscopic findings. J Cutan
Pathol, 32 (1), 28-34. doi:10.1111/j.0303-6987.2005.00254.x
Berhanu, A., Prigge, J. T., Silvera, P. M., Honeychurch, K. M., Hruby,
D. E., & Grosenbach, D. W. (2015). Treatment with the smallpox
antiviral tecovirimat (ST-246) alone or in combination with ACAM2000
vaccination is effective as a postsymptomatic therapy for monkeypox
virus infection. Antimicrobial agents and chemotherapy, 59 (7),
4296-4300.
Bhunu, C. P., Mushayabasa, S., & Hyman, J. (2012). Modelling HIV/AIDS
and monkeypox co-infection. Applied Mathematics and Computation,
218 (18), 9504-9518.
Breman, J. G. (2000). Monkeypox: an emerging infection for humans?Emerging infections 4 , 45-67.
Brown, K., & Leggat, P. A. (2016). Human Monkeypox: Current State of
Knowledge and Implications for the Future. Trop Med Infect Dis,
1 (1), 8. doi:10.3390/tropicalmed1010008
Bunge, E. M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer,
L. R., & Steffen, R. (2022). The changing epidemiology of human
monkeypox-A potential threat? A systematic review. PLoS Negl Trop
Dis, 16 (2), e0010141. doi:10.1371/journal.pntd.0010141
Costello, V., Sowash, M., Gaur, A., Cardis, M., Pasieka, H., Wortmann,
G., & Ramdeen, S. (2022). Imported Monkeypox from International
Traveler, Maryland, USA, 2021. Emerg Infect Dis, 28 (5),
1002-1005. doi:10.3201/eid2805.220292
Damon, I. K. (2011). Status of human monkeypox: clinical disease,
epidemiology and research. Vaccine, 29 Suppl 4 , D54-59.
doi:10.1016/j.vaccine.2011.04.014
Durski, K. N., McCollum, A. M., Nakazawa, Y., Petersen, B. W., Reynolds,
M. G., Briand, S., . . . Khalakdina, A. (2018). Emergence of
monkeypox—west and central Africa, 1970–2017. Morbidity and
Mortality Weekly Report, 67 (10), 306.
Echekwube, P., Mbaave, P., Abidakun, O., Utoo, B., & Swende, T. (2020).
Human Monkeypox and Human Immunodeficiency Virus Co-infection: A Case
Series in Makurdi, Benue State, Nigeria. Journal of BioMedical
Research and Clinical Practice, 3 (2), 375-381.
Edghill-Smith, Y., Golding, H., Manischewitz, J., King, L. R., Scott,
D., Bray, M., . . . Franchini, G. (2005). Smallpox vaccine-induced
antibodies are necessary and sufficient for protection against monkeypox
virus. Nat Med, 11 (7), 740-747. doi:10.1038/nm1261
Eltvedt, A. K., Christiansen, M., & Poulsen, A. (2020). A Case Report
of Monkeypox in a 4-Year-Old Boy from the DR Congo: Challenges of
Diagnosis and Management. Case Rep Pediatr, 2020 , 8572596.
doi:10.1155/2020/8572596
Erez, N., Achdout, H., Milrot, E., Schwartz, Y., Wiener-Well, Y., Paran,
N., . . . Schwartz, E. (2019). Diagnosis of Imported Monkeypox, Israel,
2018. Emerg Infect Dis, 25 (5), 980-983.
doi:10.3201/eid2505.190076
Fleischauer, A. T., Kile, J. C., Davidson, M., Fischer, M., Karem, K.
L., Teclaw, R., . . . Kuehnert, M. J. (2005). Evaluation of
human-to-human transmission of monkeypox from infected patients to
health care workers. Clin Infect Dis, 40 (5), 689-694.
doi:10.1086/427805
Grant, R., Nguyen, L. L., & Breban, R. (2020). Modelling human-to-human
transmission of monkeypox. Bull World Health Organ, 98 (9),
638-640. doi:10.2471/BLT.19.242347
Heraud, J. M., Edghill-Smith, Y., Ayala, V., Kalisz, I., Parrino, J.,
Kalyanaraman, V. S., . . . Franchini, G. (2006). Subunit recombinant
vaccine protects against monkeypox. J Immunol, 177 (4), 2552-2564.
doi:10.4049/jimmunol.177.4.2552
Hobson, G., Adamson, J., Adler, H., Firth, R., Gould, S., Houlihan, C.,
. . . Wingfield, T. (2021). Family cluster of three cases of monkeypox
imported from Nigeria to the United Kingdom, May 2021. Euro
Surveill, 26 (32). doi:10.2807/1560-7917.ES.2021.26.32.2100745
Hoff, N. A., Morier, D. S., Kisalu, N. K., Johnston, S. C., Doshi, R.
H., Hensley, L. E., . . . Rimoin, A. W. (2017). Varicella Co-infection
in Patients with Active Monkeypox in the Democratic Republic of the
Congo. Ecohealth, 14 (3), 564-574. doi:10.1007/s10393-017-1266-5
Hughes, C., McCollum, A., Pukuta, E., Karhemere, S., Nguete, B.,
Lushima, R. S., . . . Wemakoy, O. (2014). Ocular complications
associated with acute monkeypox virus infection, DRC.International Journal of Infectious Diseases, 21 , 276-277.
Hughes, C. M., Liu, L., Davidson, W. B., Radford, K. W., Wilkins, K.,
Monroe, B., . . . Kabamba, J. (2021). A Tale of Two Viruses:
Coinfections of Monkeypox and Varicella Zoster Virus in the Democratic
Republic of Congo. The American Journal of Tropical Medicine and
Hygiene, 104 (2), 604.
Huhn, G. D., Bauer, A. M., Yorita, K., Graham, M. B., Sejvar, J., Likos,
A., . . . Kuehnert, M. J. (2005). Clinical characteristics of human
monkeypox, and risk factors for severe disease. Clin Infect Dis,
41 (12), 1742-1751. doi:10.1086/498115
Hutson, C. L., Kondas, A. V., Mauldin, M. R., Doty, J. B., Grossi, I.
M., Morgan, C. N., . . . Kling, C. (2021). Pharmacokinetics and Efficacy
of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal
Monkeypox Virus Animal Model. Msphere, 6 (1), e00927-00920.
Jabeen, C., & Umbreen, G. (2017). Monkeypox transmission, need and
treatment of humans with an antiviral drug. International Journal
of Social Sciences and Management, 4 (2), 77-79.
Kabuga, A. I., & El Zowalaty, M. E. (2019). A review of the monkeypox
virus and a recent outbreak of skin rash disease in Nigeria. J Med
Virol, 91 (4), 533-540. doi:10.1002/jmv.25348
Karem, K. L., Reynolds, M., Braden, Z., Lou, G., Bernard, N., Patton,
J., & Damon, I. K. (2005). Characterization of acute-phase humoral
immunity to monkeypox: use of immunoglobulin M enzyme-linked
immunosorbent assay for detection of monkeypox infection during the 2003
North American outbreak. Clinical and Vaccine Immunology, 12 (7),
867-872.
Keckler, M. S., Salzer, J. S., Patel, N., Townsend, M. B., Nakazawa, Y.
J., Doty, J. B., . . . Karem, K. L. (2020). IMVAMUNE® and ACAM2000®
Provide Different Protection against Disease When Administered
Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model.Vaccines, 8 (3), 396.
Leong, W.-Y. (2020). COVID-19’s impact on travel medicine surpasses that
of all other emerging viral diseases. In (Vol. 27, pp. taaa221): Oxford
University Press.
Macneil, A., Reynolds, M. G., Braden, Z., Carroll, D. S., Bostik, V.,
Karem, K., . . . Damon, I. K. (2009). Transmission of atypical
varicella-zoster virus infections involving palm and sole manifestations
in an area with monkeypox endemicity. Clin Infect Dis, 48 (1),
e6-8. doi:10.1086/595552
MacNeil, A., Reynolds, M. G., Carroll, D. S., Karem, K., Braden, Z.,
Lash, R., . . . Damon, I. K. (2009). Monkeypox or varicella? Lessons
from a rash outbreak investigation in the Republic of the Congo.Am J Trop Med Hyg, 80 (4), 503-507.
Mahase, E. (2022a). Monkeypox: What do we know about the outbreaks in
Europe and North America? In: British Medical Journal Publishing Group.
Mahase, E. (2022b). Seven monkeypox cases are confirmed in England. In:
British Medical Journal Publishing Group.
Mauldin, M. R., McCollum, A. M., Nakazawa, Y. J., Mandra, A.,
Whitehouse, E. R., Davidson, W., . . . Reynolds, M. G. (2022).
Exportation of Monkeypox Virus From the African Continent. J
Infect Dis, 225 (8), 1367-1376. doi:10.1093/infdis/jiaa559
Ng, O. T., Lee, V., Marimuthu, K., Vasoo, S., Chan, G., Lin, R. T. P.,
& Leo, Y. S. (2019). A case of imported Monkeypox in Singapore.Lancet Infect Dis, 19 (11), 1166.
doi:10.1016/S1473-3099(19)30537-7
Nguyen, P. Y., Ajisegiri, W. S., Costantino, V., Chughtai, A. A., &
MacIntyre, C. R. (2021). Reemergence of Human Monkeypox and Declining
Population Immunity in the Context of Urbanization, Nigeria, 2017-2020.Emerg Infect Dis, 27 (4), 1007. doi:10.3201/eid2704.203569
Nolen, L. D., Osadebe, L., Katomba, J., Likofata, J., Mukadi, D.,
Monroe, B., & Doty, J. (2015). Introduction of monkeypox into a
community and household: risk factors and zoonotic reservoirs in the
Democratic Republic of the Congo. The American Journal of Tropical
Medicine and Hygiene, 93 (2), 410.
Ogoina, D., Iroezindu, M., James, H. I., Oladokun, R., Yinka-Ogunleye,
A., Wakama, P., . . . Ihekweazu, C. (2020). Clinical Course and Outcome
of Human Monkeypox in Nigeria. Clin Infect Dis, 71 (8), e210-e214.
doi:10.1093/cid/ciaa143
Ogoina, D., Mohammed, A., Yinka-Ogunleye, A., & Ihekweazu, C. (2022). A
case of suicide during the 2017 monkeypox outbreak in Nigeria.IJID Regions .
Parker, S., Nuara, A., Buller, R. M., & Schultz, D. A. (2007). Human
monkeypox: an emerging zoonotic disease. Future Microbiol, 2 (1),
17-34. doi:10.2217/17460913.2.1.17
Petersen, B. W. (2021). Clinical guidance for the use of JYNNEOS.
Petersen, B. W., Karem, K. L., & Damon, I. K. (2014). Orthopoxviruses:
Variola, Vaccinia, Cowpox, and Monkeypox. In Viral Infections of
Humans (pp. 501-517): Springer.
Petersen, E., Kantele, A., Koopmans, M., Asogun, D., Yinka-Ogunleye, A.,
Ihekweazu, C., & Zumla, A. (2019). Human Monkeypox: Epidemiologic and
Clinical Characteristics, Diagnosis, and Prevention. Infect Dis
Clin North Am, 33 (4), 1027-1043. doi:10.1016/j.idc.2019.03.001
Quiner, C. A., Moses, C., Monroe, B. P., Nakazawa, Y., Doty, J. B.,
Hughes, C. M., . . . Reynolds, M. G. (2017). Presumptive risk factors
for monkeypox in rural communities in the Democratic Republic of the
Congo. PloS one, 12 (2), e0168664.
doi:10.1371/journal.pone.0168664
Rao, A. K., Schulte, J., Chen, T.-H., Hughes, C. M., Davidson, W., Neff,
J. M., . . . Liddell, A. (2022). Monkeypox in a Traveler Returning from
Nigeria—Dallas, Texas, July 2021. Morbidity and Mortality Weekly
Report, 71 (14), 509.
Rao, A. K., Schulte, J., Chen, T. H., Hughes, C. M., Davidson, W., Neff,
J. M., . . . July Monkeypox Response, T. (2022). Monkeypox in a Traveler
Returning from Nigeria - Dallas, Texas, July 2021. MMWR Morb
Mortal Wkly Rep, 71 (14), 509-516. doi:10.15585/mmwr.mm7114a1
Reed, K. D., Melski, J. W., Graham, M. B., Regnery, R. L., Sotir, M. J.,
Wegner, M. V., . . . Damon, I. K. (2004). The detection of monkeypox in
humans in the Western Hemisphere. N Engl J Med, 350 (4), 342-350.
doi:10.1056/NEJMoa032299
Reynolds, M. G., Carroll, D. S., & Karem, K. L. (2012). Factors
affecting the likelihood of monkeypox’s emergence and spread in the
post-smallpox era. Curr Opin Virol, 2 (3), 335-343.
doi:10.1016/j.coviro.2012.02.004
Reynolds, M. G., & Damon, I. K. (2012). Outbreaks of human monkeypox
after cessation of smallpox vaccination. Trends Microbiol, 20 (2),
80-87. doi:10.1016/j.tim.2011.12.001
Reynolds, M. G., Davidson, W. B., Curns, A. T., Conover, C. S., Huhn,
G., Davis, J. P., . . . Damon, I. K. (2007). Spectrum of infection and
risk factors for human monkeypox, United States, 2003. Emerg
Infect Dis, 13 (9), 1332-1339. doi:10.3201/eid1309.070175
Reynolds, M. G., Yorita, K. L., Kuehnert, M. J., Davidson, W. B., Huhn,
G. D., Holman, R. C., & Damon, I. K. (2006). Clinical manifestations of
human monkeypox influenced by route of infection. J Infect Dis,
194 (6), 773-780. doi:10.1086/505880
Russo, A. T., Berhanu, A., Bigger, C. B., Prigge, J., Silvera, P. M.,
Grosenbach, D. W., & Hruby, D. (2020). Co-administration of tecovirimat
and ACAM2000 in non-human primates: Effect of tecovirimat treatment on
ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus
challenge. Vaccine, 38 (3), 644-654.
doi:10.1016/j.vaccine.2019.10.049
Seguin, D., & Stoner Halpern, J. (2004). Triage of a febrile patient
with a rash: a comparison of chickenpox, monkeypox, and smallpox.Disaster Manag Response, 2 (3), 81-86.
doi:10.1016/j.dmr.2004.06.013
Sejvar, J. J., Chowdary, Y., Schomogyi, M., Stevens, J., Patel, J.,
Karem, K., . . . Damon, I. K. (2004). Human monkeypox infection: a
family cluster in the midwestern United States. J Infect Dis,
190 (10), 1833-1840. doi:10.1086/425039
Silenou, B. C., Tom-Aba, D., Adeoye, O., Arinze, C. C., Oyiri, F.,
Suleman, A. K., . . . Krause, G. (2020). Use of surveillance outbreak
response management and analysis system for human monkeypox outbreak,
Nigeria, 2017–2019. Emerging infectious diseases, 26 (2), 345.
Simpson, K., Heymann, D., Brown, C. S., Edmunds, W. J., Elsgaard, J.,
Fine, P., . . . Ihekweazu, C. (2020). Human monkeypox–After 40 years,
an unintended consequence of smallpox eradication. Vaccine,
38 (33), 5077-5081.
Smith, S. K., Olson, V. A., Karem, K. L., Jordan, R., Hruby, D. E., &
Damon, I. K. (2009). In vitro efficacy of ST246 against smallpox and
monkeypox. Antimicrob Agents Chemother, 53 (3), 1007-1012.
doi:10.1128/AAC.01044-08
Tabasi, S. (2018). Skin rashes that involve palms and soles: an
internist’s view. Ann Nurs Primary Care. 2018; 1 (2), 1012 .
Uwishema, O., Adanur, I., Babatunde, A. O., Hasan, M. M., Elmahi, O. K.
O., Olajumoke, K. B., . . . Essar, M. Y. (2021). Viral infections amidst
COVID-19 in Africa: Implications and recommendations. J Med Virol,
93 (12), 6798-6802. doi:10.1002/jmv.27211
Vaughan, A., Aarons, E., Astbury, J., Balasegaram, S., Beadsworth, M.,
Beck, C. R., . . . Wilburn, J. (2018a). Two cases of monkeypox imported
to the United Kingdom, September 2018. Euro Surveill, 23 (38),
1800509. doi:10.2807/1560-7917.ES.2018.23.38.1800509
Vaughan, A., Aarons, E., Astbury, J., Balasegaram, S., Beadsworth, M.,
Beck, C. R., . . . Wilburn, J. (2018b). Two cases of monkeypox imported
to the United Kingdom, September 2018. Euro Surveill, 23 (38).
doi:10.2807/1560-7917.Es.2018.23.38.1800509
Vaughan, A., Aarons, E., Astbury, J., Brooks, T., Chand, M., Flegg, P.,
. . . Dunning, J. (2020). Human-to-Human Transmission of Monkeypox
Virus, United Kingdom, October 2018. Emerg Infect Dis, 26 (4),
782-785. doi:10.3201/eid2604.191164
Walensky, R. P. (2022). Centers for Disease Control and Prevention
justification of appropriation estimates for Appropriations Committees
fiscal year 2023.
Walker, M. (2022). Monkeypox Virus Hosts and Transmission Routes: A
Systematic Review of a Zoonotic Pathogen.
Wardiana, M., Rahmadewi, D. M., & Sawitri, D. (2021). Chickenpox
Mimicking Monkeypox in Adult with Diabetes Mellitus and Acute Kidney
Injury: Diagnosis and Management. Berkala Ilmu Kesehatan Kulit dan
Kelamin, 33 (3), 213-223.
Weinstein, R. A., Nalca, A., Rimoin, A. W., Bavari, S., & Whitehouse,
C. A. (2005). Reemergence of monkeypox: prevalence, diagnostics, and
countermeasures. Clinical Infectious Diseases, 41 (12), 1765-1771.
Xiao, Y., & Isaacs, S. N. (2010). Therapeutic Vaccines and Antibodies
for Treatment of Orthopoxvirus Infections. Viruses, 2 (10),
2381-2403. doi:10.3390/v2102381
Yinka-Ogunleye, A., Aruna, O., Dalhat, M., Ogoina, D., McCollum, A.,
Disu, Y., . . . Team, C. D. C. M. O. (2019). Outbreak of human monkeypox
in Nigeria in 2017-18: a clinical and epidemiological report.Lancet Infect Dis, 19 (8), 872-879.
doi:10.1016/S1473-3099(19)30294-4